BACTERIAL INFECTIONS
Clinical trials for BACTERIAL INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new BACTERIAL INFECTIONS trials appear
Sign up with your email to follow new studies for BACTERIAL INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to slash infection risk in blood cancer patients
Disease control Recruiting nowThis study tests whether adding XEMBIFY (an antibody-boosting medicine) to standard treatment can reduce serious bacterial infections in adults with certain blood cancers (chronic lymphocytic leukemia, multiple myeloma, or non-Hodgkin lymphoma) who also have low antibody levels. …
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE3 • Sponsor: Grifols Therapeutics LLC • Aim: Disease control
Last updated Apr 29, 2026 05:00 UTC
-
New antibiotic safety study for kidney patients launches
Knowledge-focused Recruiting nowThis early-stage study is testing a new antibiotic called Cefiderocol/Xeruborbactam in 40 adults with different levels of kidney function, including those on dialysis. The main goal is to see how safe the drug is and how the body processes it after a single dose. This information…
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE1 • Sponsor: Qpex Biopharma, Inc. • Aim: Knowledge-focused
Last updated Apr 29, 2026 04:58 UTC
-
New antibiotic candidate JKN2501 begins first human safety tests
Knowledge-focused Recruiting nowThis early-stage study tests whether a new drug called JKN2501 is safe in healthy adults and how the body processes it. About 66 healthy volunteers aged 18-45 will receive either the drug or a placebo by IV. The goal is to gather safety information, not to treat any disease.
Matched conditions: BACTERIAL INFECTIONS
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Apr 29, 2026 04:58 UTC